Biosig Technologies (BSGM)
(Delayed Data from OTC)
$0.34 USD
0.00 (0.00%)
Updated Sep 23, 2024 03:28 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Biosig Technologies, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 0 | 0 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 0 | 0 | 0 | 0 | 0 |
Selling & Adminstrative & Depr. & Amort Expenses | 29 | 27 | 34 | 59 | 35 |
Income After Depreciation & Amortization | -29 | -27 | -33 | -59 | -35 |
Non-Operating Income | 0 | 0 | 1 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -29 | -27 | -33 | -59 | -34 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | -1 | -7 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -29 | -27 | -33 | -59 | -34 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -29 | -27 | -32 | -52 | -34 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -28 | -27 | -33 | -59 | -35 |
Depreciation & Amortization (Cash Flow) | 0 | 0 | 1 | 1 | 0 |
Income After Depreciation & Amortization | -29 | -27 | -33 | -59 | -35 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 7.35 | 4.26 | NA | 2.79 | 2.07 |
Diluted EPS Before Non-Recurring Items | -3.95 | -6.40 | NA | -18.70 | -16.50 |
Diluted Net EPS (GAAP) | -3.95 | -6.40 | -9.50 | -18.70 | -16.50 |
Fiscal Year end for Biosig Technologies, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 |
SG&A, R&D, and Dept/Amort Expenses | 5.30 | 3.46 | 6.18 | 4.06 | 10.91 |
Income After SG&A, R&D, and Dept/Amort Expenses | -5.29 | -3.45 | -6.17 | -4.06 | -10.91 |
Non-Operating Income | 1.39 | 0.03 | 0.04 | 0.00 | -0.23 |
Interest Expense | -0.01 | 0.00 | -0.02 | 0.00 | 0.00 |
Pretax Income | -3.91 | -3.42 | -6.13 | -4.05 | -11.13 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | -0.01 | -0.08 | 0.52 | -0.04 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -3.91 | -3.42 | -6.13 | -4.05 | -11.13 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -3.92 | -3.40 | -6.05 | -4.57 | -11.09 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 12.92 | 9.86 | NA | 7.54 | 7.03 |
Diluted EPS Before Non-Recurring Items | -0.30 | -0.36 | NA | -0.60 | -1.60 |
Diluted Net EPS (GAAP) | -0.30 | -0.36 | -0.55 | -0.60 | -1.60 |